OPEN END TURBO LONG - QUEST DIAGNOSTICS | Market Closed - Börse Stuttgart 15:11:39 2024-05-10 EDT | ||
| 1.35 EUR | -1.46% |
|
| Current month | -6.90% | ||
| 1 month | +55.17% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about QUEST DIAGNOSTICS INCORPORATED
More news
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-10 | 1.35 | -1.46% | 0 |
| 24-05-09 | 1.37 | +8.73% | 0 |
| 24-05-08 | 1.26 | 0.00% | 0 |
| 24-05-07 | 1.26 | +6.78% | 0 |
| 24-05-06 | 1.18 | -4.07% | 0 |
Delayed Quote Börse Stuttgart
Last update May 10, 2024 at 03:11 pm
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | QUEST DIAGNOSTICS INCORPORATED |
| Issuer | Morgan Stanley |
| WKN | ME4SK5 |
| ISIN | DE000ME4SK53 |
| Date issued | 2023-12-06 |
| Strike | 124.2 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 1.66 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 2.01 € |
|---|---|
| Lowest since issue | 0.189 € |
Company Profile
Quest Diagnostics is the world's leading provider of diagnostics testing and information service for patients and health professionals. Net sales break down by activity as follows:
- testing and diagnostic services (97.3%): routine clinical testing, gene-based testing and advanced diagnostic and anatomica pathology diagnostic services;
- other (2.7%).
Sector
-
Ratings for Quest Diagnostics Incorporated
Trading Rating
Investor Rating
ESG Refinitiv
A-
Consensus: Quest Diagnostics Incorporated
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
138.4
USD
Average target price
146.7
USD
Spread / Average Target
+6.01%
- Stock Market
- Certificates
- Certificat